Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil
Completed · Phase 3 · NCT03399604
Conditions: Primary Pulmonary Hypertension
At a glance
- Research payments reported, 2025
- $58,113
- U.S. investigators named
- 7
- Sites paid
- 7
- Planned or actual enrollment
- 121
About the trial
- Sponsor
- Liquidia Technologies, Inc. (with Nuventra, Inc.)
- Tested
- LIQ861 Inhaled Treprostinil (drug)
- Dates
- Started 2018-01-02; completion 2019-11-25
- Results posted
- Yes
The primary objective of this study is to evaluate the long-term safety and tolerability of LIQ861, a dry powder formulation of treprostinil, in patients with Pulmonary Arterial Hypertension (PAH).
From ClinicalTrials.gov, last updated 2024-07-30. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Liquidia Technologies, Inc. reported $58,113 in research payments for this study in 2025 (38 payments).
Products named: Yutrepia
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Rajan Saggar, MD Pulmonology · Los Angeles, CA
- Ricardo Restrepo-jaramillo, M.D. Pulmonology · Tampa, FL
- Vallerie V. Mclaughlin, MD Cardiology · Ann Arbor, MI
- James W. Fordyce, DO Orthopedic Surgery · Hayesville, NC
- Rachana Krishna, M.D. Pulmonology · Charleston, SC
- Mohi U. Syed, MD Pulmonology · Houston, TX
- John J. Ryan, MBBCHBAO Cardiology · Salt Lake City, UT
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University of Utah Hospital and Clinics, UT $17,762
- Houston Methodist Hopsital $12,211
- Ronald Reagan UCLA Medical Center, CA $7,441
- University of Michigan Health System, MI $6,994
- University of Florida Board of Trustees $6,797
- Medical University of South Carolina $6,268
- University of North Carolina at Chapel Hill $640
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.